Ignite Creation Date:
2024-05-06 @ 7:42 PM
Last Modification Date:
2025-12-17 @ 12:41 PM
Study NCT ID:
NCT06103357
Status:
None
Last Update Posted:
2024-03-05 00:00:00
First Post:
2023-10-23 00:00:00
Brief Title:
Identification of Biomarkers in Subjects With Coronary Syndrome (PLAQUE Study)
Sponsor:
Istituto Nazionale di Ricovero e Cura per Anziani
Organization:
Istituto Nazionale di Ricovero e Cura per Anziani
Study Overview
Official Title:
Identification of Innovative Circulating and Cellular Biomarkers in Subjects With Acute and Chronic Coronary Syndrome (PLAQUE Study)
Status:
None
Status Verified Date:
2023-10
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PLAQUE
Brief Summary:
Twenty patients with acute coronary syndrome from non-ST-segment elevation myocardial infarction or with chronic coronary syndrome with clinical indication and favorable anatomy for coronary angioplasty will be enrolled. The angioplasty procedure will be performed according to standard clinical practice. Before and after angioplasty, blood samples will be taken upstream and downstream of the coronary lesion, arterial sampling will be performed at the level of the aortic root, and peripheral venous blood will be collected. MicroRNA expression will be analyzed in serum by next-generation sequencing (miRNome). Quantitative analysis of pro- and anti-inflammatory molecules such as IL-6 and the soluble form of IL-33 receptor (sST2) will be performed on various blood samples.
Detailed Description:
Twenty patients with acute coronary syndrome from non-ST-segment elevation myocardial infarction or with chronic coronary syndrome with clinical indication and favorable anatomy for coronary angioplasty will be enrolled The angioplasty procedure will be performed according to standard clinical practice Before and after angioplasty blood samples will be taken upstream and downstream of the coronary lesion arterial sampling will be performed at the level of the aortic root and peripheral venous blood will be collected MicroRNA expression will be analyzed in serum by next-generation sequencing miRNome Quantitative analysis of pro- and anti-inflammatory molecules such as IL-6 and the soluble form of IL-33 receptor sST2 will be performed on various blood samples
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None